Federated Hermes’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
16,528
+4,577
| +38% | +$61.9K | ﹤0.01% | 1473 |
|
|
2025
Q1 | $190K | Sell |
11,951
-3,565
| -23% | -$56.6K | ﹤0.01% | 1494 |
|
|
2024
Q4 | $191K | Sell |
15,516
-1,332
| -8% | -$16.4K | ﹤0.01% | 1487 |
|
|
2024
Q3 | $204K | Buy |
16,848
+4,848
| +40% | +$58.7K | ﹤0.01% | 1475 |
|
|
2024
Q2 | $140K | Buy |
12,000
+6,000
| +100% | +$70.2K | ﹤0.01% | 1528 |
|
|
2024
Q1 | $77.5K | Sell |
6,000
-14,032
| -70% | -$181K | ﹤0.01% | 1590 |
|
|
2023
Q4 | $172K | Sell |
20,032
-2,261
| -10% | -$19.4K | ﹤0.01% | 1530 |
|
|
2023
Q3 | $212K | Buy |
22,293
+1,700
| +8% | +$16.2K | ﹤0.01% | 1516 |
|
|
2023
Q2 | $351K | Buy |
+20,593
| New | +$351K | ﹤0.01% | 1465 |
|